demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
antiviral and associated therapy
azithromycin COALITION I Covid-19 Brazil ... Rashad A ...
azvudine Ren
bromhexine Li T
chloroquine and derivatives
hydroxychloroquine Coalition Covid-19 Brazil I ... FACCT Trial
Ensitrelvir (XOCOVA) Mukae - Phase 2a
favipiravir NCT04542694 Ruzhentsova T FACCT Trial Dabbous HM Shinkai Udwadia AVIFAVIR Solaymani-Dodaran
favipiravir plus interferon Khamis
hydroxychloroquine plus macrolides
azithromycin plus hydroxychloroquine Coalition Covid-19 Brazil I ...
ivermectin Kirti Krolewiecki I-TECH ... Chaccour Shahbaznejad
ivermectin plus doxycycline NCT04523831 ...
lopinavir/ritonavir ELACOI ...
lopinavir/ritonavir, ribavirin and interferon beta-1b Hung et al.
remdesivir GS-US-540-5774, 5 days GS-US-540-5773 ... GS-US-540-5774, 10 days
sofosbuvir and ledipasvir Nourian A
umifenovir (arbidol) ELACOI ...

25 studies excluded by filtering options 0

5989 Yethindra, 2020 113high risk of bias
6064 Glorial F, 2020 1100not a RCTrisk of bias not avaialble
6083 IFORS (Pott-Junior), 2020 213excludedhigh risk of bias
6244 Holubar M, 2021 110risk of bias not avaialble
6248 IRCT20151227025726N14 // U07, 0 010selection pending
6265 Shenoy S, 2021 113high risk of bias
6369 Ahmed, 2020 113high risk of bias
6370 Chachar, 2020 113high risk of bias
6381 Espitia-Hernandez, 2020 1310not a RCTrisk of bias not avaialble
6381 Espitia-Hernandez, 2020 1310not a RCTrisk of bias not avaialble
6382 Khan, 2020 0130selection pending
6383 Soto-Becerra, 2020 0122selection pending
6384 Spoorthi, 2020 1310not a RCTrisk of bias not avaialble
6384 Spoorthi, 2020 1310not a RCTrisk of bias not avaialble
6411 Rocco, 2020 113high risk of bias
6526 Dabbous, 2021 213excludedhigh risk of bias
6575 Bukhari, 2021 113high risk of bias
6624 Babalola, 2021 113high risk of bias
6625 Nasir, 2020 2310excludednot a RCTrisk of bias not avaialble
6626 RIVET-COV (Mohan) (12mg and 24mg), 2021 113high risk of bias
6675 Silva, 2021 113high risk of bias
7313 Abd-Elsalam, 2021 113high risk of bias
7319 Fontanesi, 2021 110risk of bias not avaialble
7995 Hazan, 2021 2320excludednot a RCTrisk of bias not avaialble
9462 Mayer, 2022 000selection pending